Bromberg JEC, Issa S, van der Holt B, van der Meulen M, et al. Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study. Neuro Oncol 2024;26:724-734.
PMID: 38037691